Rotavirus Experts Share Latest Research, Call for Increased Vaccine Coverage at Symposium

MINSK, BELARUS – Beginning today, the 13th International Rotavirus Symposium, hosted by the Sabin Vaccine Institute, the U.S. Centers for Diseases Control, PATH, ROTA Council, the Fogarty International Center at the U.S. National Institutes of Health, the Government of the Republic of Belarus, and the Bill & Melinda Gates Foundation, is bringing together scientific experts, policy makers and public health officials to share the latest developments in the fast-moving field of rotavirus prevention.
08.29.18 to 08.31.18
Minsk, Belarus

Amy Finan, chief executive officer of the Sabin Vaccine Institute, discussed Sabin’s commitment to vaccine development and the challenges of developing and bringing vaccines to market.

Why is Sabin committed to vaccine development?

In 2014, the Sabin Vaccine Institute began working with Georgia’s national government and partners to promote sustainable immunization financing and domestic resource mobilization for immunization. In more recent years, the focus has shifted to improving government immunization policy.

Typhoid is a common illness across much of Southeast Asia, where the bacterial disease spreads through contaminated food and water.

For 25 years, Sabin has been a trusted partner, working with countries, the World Health Organization (WHO), Gavi, the Vaccine Alliance, the Bill and Melinda Gates Foundation, and regional stakeholders to improve immunization.

When the Sabin Vaccine Institute’s Coalition against Typhoid held our most recent global conference in 2017, we could hardly have foreseen that it would be the